Nanoformulated fingolimod for spinal cord injury: promising anti‑neuroinflammatory effects but unsubstantiated bioavailability claims.
- DOI
- 10.1038/s41393-026-01241-x
- Published
- 2026 Aug
- Container
- Spinal cord
- Publisher
- Not recorded
- Open access
- unknown
Credibility signals
limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1038/s41393-026-01241-x,
title = {Nanoformulated fingolimod for spinal cord injury: promising anti‑neuroinflammatory effects but unsubstantiated bioavailability claims.},
author = {Jasur R and Zokir R and Mukarram S and Akhmedova N and Gulhayo A and Latipov J and Abroumand Gholami A},
year = {2026},
journal = {Spinal cord},
doi = {10.1038/s41393-026-01241-x},
url = {https://doi.org/10.1038/s41393-026-01241-x}
}RIS
TY - JOUR TI - Nanoformulated fingolimod for spinal cord injury: promising anti‑neuroinflammatory effects but unsubstantiated bioavailability claims. AU - Jasur R AU - Zokir R AU - Mukarram S AU - Akhmedova N AU - Gulhayo A AU - Latipov J AU - Abroumand Gholami A PY - 2026 JO - Spinal cord DO - 10.1038/s41393-026-01241-x UR - https://doi.org/10.1038/s41393-026-01241-x ER -
APA
R, J., R, Z., S, M., N, A., A, G., J, L., & A, A. G. (2026). Nanoformulated fingolimod for spinal cord injury: promising anti‑neuroinflammatory effects but unsubstantiated bioavailability claims.. Spinal cord. https://doi.org/10.1038/s41393-026-01241-x
Source records
- pubmed · retrieved 2026-09-26T18:53:02.304Z